All Industries

Top Biotech Companies

3,138 Biotech companies, sorted by total funding raised.

DNA Script

DNA Script develops the SYNTAX platform for enzymatic DNA synthesis, enabling labs to print high-...

Paris, France51–200Biotech, Synthetic Biology
Series C·$466.5M·Jan 2022
InvivydIPO

Biotechnology company developing antibody-based therapies against evolving viral threats includin...

Waltham, United States51–200healthtech, Biotech
Funding undisclosed
ArvinasIPO

Clinical-stage biotechnology company developing PROTAC protein degraders for oncology and neurode...

New Haven, United States201–500Biotech, Healthcare
Private Equity·$464.9M·Nov 2023
BiofourmisAcquired

AI-driven platform delivering remote patient monitoring and in-home care for health systems, paye...

Boston, United States201–500Artificial Intelligence, Digital Health
Series D·$461.5M·Jul 2022
Nektar TherapeuticsIPO

Research-based development stage biopharmaceutical company that discovers and develops innovative...

San Francisco, United States51–200biotech, immunotherapy
Corporate Round·$460.0M·Feb 2026
ImmunomedicsClosed

Biotechnology company focused on the development of antibody-drug conjugates for the treatment of...

Morris Plains, United States201–500biotechnology, oncology
Private Equity·$459.0M·May 2020
Crinetics Pharmaceuticals, Inc.

R&D company with 6 SBIR/STTR awards from Department of Health and Human Services.

San Diego, United States11–50Biotech, Healthcare
Venture Unknown·$453.5M·Jan 2026
Phathom PharmaceuticalsIPO

Phathom Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing ...

Florham Park, United States201–500Biotech, GI Health
Venture Unknown·$450.3M·May 2023
GalectoIPO

Clinical-stage biotech developing small-molecule therapeutics targeting galectin and other mechan...

Copenhagen, Denmark11–50Biotech, Drug Development
Series C·$446.9M·Nov 2025
X4 PharmaceuticalsIPO

Clinical-stage biopharmaceutical company developing novel, oral medicines designed to treat a ran...

Boston, United States51–200Biotech, Drug Discovery
Series C·$446.8M·Oct 2025
Avenzo

Avenzo is a San Diego, CA-based biopharma company to in-license and develop the next generation o...

San Diego, United States1–10Biotech, Oncology
Series B·$446.0M·Sep 2025
Helix

Population genomics and viral surveillance company enabling health systems and public health orga...

San Mateo, United States201–500Biotech, Diagnostics
Series C·$435.0M·Jun 2021
Verve TherapeuticsAcquired

Develops one-time in vivo gene-editing medicines to prevent and treat atherosclerotic cardiovascu...

Boston, United States201–500Biotech, Drug Discovery
Series C·$428.5M·Oct 2024
Areteia TherapeuticsClosed

Clinical-stage biotechnology developing an oral eosinophil-maturation inhibitor (dexpramipexole) ...

Chapel Hill, United States11–50Biotech, Life Sciences
Series A·$425.0M·Feb 2024
BioNTech

German biotech company developing mRNA-based immunotherapies and vaccines.

Mainz, Germany5001–10000Biotech, Healthcare
Series A·$425.0M·Jan 2019
Angitia Biopharmaceuticals

Clinical-stage biotech developing novel bispecific antibody therapies for musculoskeletal and bon...

Westlake Village, United States51–200Biotech, Healthcare
Series D·$420.0M·Feb 2026
Benchling

Unlocking the power of biotech with modern software for modern science

San Francisco, United States501–1000Biotech, SaaS
Series F·$412.0M·Nov 2021
Verdiva Bio

Verdiva Bio is a clinical-stage biopharmaceutical company focused on developing innovative therap...

London, United Kingdom11–50Life Sciences, Biotech
Series A·$411.0M·Jan 2025
Sonoma Biotherapeutics

Develops engineered regulatory T cell therapies to restore immune balance and treat autoimmune an...

Seattle, United States51–200Biotech, Life Sciences
Corporate Round·$410.0M·Sep 2024
Abcuro

Abcuro is a clinical-stage company developing Ulviprubart, a FIC anti-KLRG1 antibody in Ph2/3 piv...

Newton, United States51–200Biotech, Healthcare
Series C·$407.3M·Feb 2025
BillionToOneIPO

The genetic testing platform detecting and measuring disease.

Menlo Park, United States201–500Diagnostics, Genomics
Venture Unknown·$406.0M·Mar 2026
Athelas

Digital tools for healthcare providers

Mountain View, United States51–200Biotech, Healthcare
Growth Equity·$404.0M·Jun 2025
Color

Population-scale health company delivering genetic testing, cancer screening, and virtual clinica...

Burlingame, United States501–1000Life Sciences, Biotech
Series E·$402.0M·Nov 2021
Upstream BioIPO

Clinical-stage biotechnology company developing treatments for inflammatory diseases, with an ini...

Waltham, United States51–200healthtech, Biotech
Series B·$400.0M·Jun 2023
Syneron Bio

Biotech company focused on biologics development.

Beijing, United States51–200Biotech, Healthcare
Venture Unknown·$400.0M·Apr 2026